Skip to main content

M FE4 (Fenofibrate 145 mg)

Pill with imprint M FE4 is White, Elliptical/Oval and has been identified as Fenofibrate 145 mg. It is supplied by Mylan Pharmaceuticals Inc.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M FE4

Fenofibrate 145 mg M FE4 Front
Fenofibrate 145 mg M FE4 Back
Fenofibrate 145 mg M FE4
Fenofibrate 145 mg M FE4

Fenofibrate

Imprint
M FE4
Strength
145 mg
Color
White
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, soya lecithin, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-3066 Mylan Pharmaceuticals Inc.
51079-0608 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M FE4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.